Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Core EBITDA Margin

    Back to All Ratios
AD     Remove this Ad

LASA SUPERGENERICS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 2.13-5.0911.6823.3317.91

What is the latest Core EBITDA Margin ratio of LASA SUPERGENERICS ?

The latest Core EBITDA Margin ratio of LASA SUPERGENERICS is 2.13 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20242.13
Mar2023-5.09
Mar202211.68
Mar202123.33
Mar202017.91

How is Core EBITDA Margin of LASA SUPERGENERICS Trending?

Years Core EBITDA Margin % Change
Mar2024 2.13
Positive
Mar2023 -5.09
Negative
Mar2022 11.68
-49.94
Mar2021 23.33
30.26
Mar2020 17.91 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Core EBITDA Margin ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹39.5 Cr 9.3% -1% -56.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,083.0 Cr -1% -7% -1% Stock Analytics
DIVIS LABORATORIES ₹163,971.0 Cr 5% -2.7% 15.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,660.0 Cr 3.2% -6.2% 29.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,686.0 Cr 2.3% -8.1% 13.5% Stock Analytics
CIPLA ₹99,086.7 Cr 0.9% -7.8% -12.5% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

9.3%

-1%

-56.3%

SENSEX

4.7%

-0.1%

3.6%


You may also like the below Video Courses